David D. Jones

David D. Jones is Managing Director for Merck Canada. In this role, he is responsible for leading operations across Merck’s Canadian subsidiary. David came to Canada following three years in Japan as Executive Officer and Head of Primary Care, Vaccines, & Specialty Medicines for MSD Japan. During his tenure in the biopharmaceutical industry, David has held US and Global commercial leadership roles spanning Vaccines, Respiratory, Cardiovascular, Rare Disease, Oncology, and Infectious Disease therapeutic areas while also leading the establishment of Merck’s commercial data and advanced analytics organization.  

Merck Canada is the Canadian subsidiary of Merck & Co, one of the world’s largest research-driven biopharmaceutical companies. Headquartered in Kirkland, Quebec, the company develops and commercializes medicines, vaccines and health solutions across areas including oncology, infectious diseases, vaccines, cardio-metabolic conditions and specialty care. Merck Canada also supports clinical research and partnerships across the Canadian healthcare ecosystem, with a focus on improving access to innovation and advancing patient outcomes through science-led healthcare solutions.